Inventor
HEYES JAMES
CA32 patents
⚠️ This page may combine multiple inventors who share the name “HEYES JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARBUTUS BIOPHARMA CORP
12 patentsUS10561732B2Feb 18, 2020
Trialkyl cationic lipids and methods of use thereof
ARBUTUS BIOPHARMA CORP13 citations94
US12016929B2Jun 25, 2024
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP5 citations86
US11786598B2Oct 17, 2023
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP7 citations86
US11446383B2Sep 20, 2022
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP6 citations86
US11427823B2Aug 30, 2022
Targeted compositions
ARBUTUS BIOPHARMA CORP5 citations82
US11191849B2Dec 7, 2021
Compositions and methods for delivering messenger RNA
ARBUTUS BIOPHARMA CORP10 citations79
US11395854B2Jul 26, 2022
Trialkyl cationic lipids and methods of use thereof
ARBUTUS BIOPHARMA CORP1 citations73
US12350383B2Jul 8, 2025
Cationic lipids containing silicon
ARBUTUS BIOPHARMA CORP0 citations61
US12043833B2Jul 23, 2024
Targeted compositions
ARBUTUS BIOPHARMA CORP1 citations60
US12251470B2Mar 18, 2025
Lipid nanoparticle formulations
ARBUTUS BIOPHARMA CORP0 citations55
US11896672B2Feb 13, 2024
Targeted nucleic acid conjugate compositions
ARBUTUS BIOPHARMA CORP0 citations52
US12357705B2Jul 15, 2025
Negatively charged peg-lipid conjugates
ARBUTUS BIOPHARMA CORP0 citations50
PROTIVA BIOTHERAPEUTICS INC
9 patentsUS9352042B2May 31, 2016
Trialkyl cationic lipids and methods of use thereof
PROTIVA BIOTHERAPEUTICS INC121 citations99
US7799565B2Sep 21, 2010
Lipid encapsulated interfering RNA
PROTIVA BIOTHERAPEUTICS INC367 citations99
US7745651B2Jun 29, 2010
Cationic lipids and methods of use
PROTIVA BIOTHERAPEUTICS INC368 citations99
US7982027B2Jul 19, 2011
Lipid encapsulated interfering RNA
PROTIVA BIOTHERAPEUTICS INC228 citations98
US7807815B2Oct 5, 2010
Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
PROTIVA BIOTHERAPEUTICS INC68 citations98
US7803397B2Sep 28, 2010
Polyethyleneglycol-modified lipid compounds and uses thereof
PROTIVA BIOTHERAPEUTICS INC313 citations98
US9018187B2Apr 28, 2015
Cationic lipids and methods for the delivery of therapeutic agents
PROTIVA BIOTHERAPEUTICS INC116 citations96
US9878042B2Jan 30, 2018
Lipid formulations for delivery of therapeutic agents to solid tumors
PROTIVA BIOTHERAPEUTICS INC23 citations94
US9926560B2Mar 27, 2018
Lipid encapsulating interfering RNA
PROTIVA BIOTHERAPEUTICS INC6 citations84
HEYES JAMES
5 patentsUS8466122B2Jun 18, 2013
Trialkyl cationic lipids and methods of use thereof
HEYES JAMES203 citations98
US8569256B2Oct 29, 2013
Cationic lipids and methods for the delivery of therapeutic agents
HEYES JAMES485 citations97
US8936942B2Jan 20, 2015
Polyethyleneglycol-modified lipid compounds and uses thereof
HEYES JAMES111 citations96
US10077232B2Sep 18, 2018
Cyclic cationic lipids and methods of use
HEYES JAMES15 citations84
US8865675B2Oct 21, 2014
Compositions and methods for silencing apolipoprotein B
HEYES JAMES12 citations83